Brought to you by 
MedCath nets $39.7mm with follow-on public offering
07 Dec 2006
Executive Summary
MedCath (focused on the diagnosis and treatment of cardiovascular conditions) has netted $39.7mm with the follow-on public offering of 1.7mm common shares priced at $25 each. Selling shareholders also offered 3.2mm common shares (including the overallotment) as part of the financing.
Deal Industry
- In Vitro Diagnostics
- Services
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MedCath nets $39.7mm with follow-on public offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice